These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31439817)

  • 1. An in situ high-throughput screen identifies inhibitors of intracellular
    Bulterys PL; Toesca IJ; Norris MH; Maloy JP; Fitz-Gibbon ST; France B; Toffig B; Morselli M; Somprasong N; Pellegrini M; Schweizer HP; Tuanyok A; Damoiseaux R; French CT; Miller JF
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18597-18606. PubMed ID: 31439817
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
    Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
    J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
    Galyov EE; Brett PJ; DeShazer D
    Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
    Feterl M; Govan B; Engler C; Norton R; Ketheesan N
    Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH Alkalinization by Chloroquine Suppresses Pathogenic Burkholderia Type 6 Secretion System 1 and Multinucleated Giant Cells.
    Chua J; Senft JL; Lockett SJ; Brett PJ; Burtnick MN; DeShazer D; Friedlander AM
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27799332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a novel whole animal HTS technology platform for melioidosis drug discovery.
    Lakshmanan U; Yap A; Fulwood J; Yichun L; Hoon SS; Lim J; Ting A; Sem XH; Kreisberg JF; Tan P; Tan G; Flotow H
    Comb Chem High Throughput Screen; 2014; 17(9):790-803. PubMed ID: 25329838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Madagascar hissing cockroach as a novel surrogate host for Burkholderia pseudomallei, B. mallei and B. thailandensis.
    Fisher NA; Ribot WJ; Applefeld W; DeShazer D
    BMC Microbiol; 2012 Jun; 12():117. PubMed ID: 22892068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against
    Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
    [No Abstract]   [Full Text] [Related]  

  • 9. Peptidyl-Prolyl Isomerase
    Bzdyl NM; Scott NE; Norville IH; Scott AE; Atkins T; Pang S; Sarovich DS; Coombs G; Inglis TJJ; Kahler CM; Sarkar-Tyson M
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331957
    [No Abstract]   [Full Text] [Related]  

  • 10. Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis.
    Gilad J
    Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):233-41. PubMed ID: 18221181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive identification of virulence factors required for respiratory melioidosis using Tn-seq mutagenesis.
    Gutierrez MG; Yoder-Himes DR; Warawa JM
    Front Cell Infect Microbiol; 2015; 5():78. PubMed ID: 26583079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro antibiotic susceptibility compliance with efficacy of chemotherapy in infections due to pathogenic Burkholderias].
    Iliukhin VI; Senina TV; Trushkina MN; Shubnikova EV; Antonov IuV; Andropova NV
    Antibiot Khimioter; 2009; 54(7-8):19-23. PubMed ID: 20201399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LVS Δ
    Tullius MV; Bowen RA; Back PS; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2024 Apr; 15(4):e0018624. PubMed ID: 38511933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present and future therapeutic strategies for melioidosis and glanders.
    Estes DM; Dow SW; Schweizer HP; Torres AG
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):325-38. PubMed ID: 20192686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating New Compounds to Treat
    Ross BN; Myers JN; Muruato LA; Tapia D; Torres AG
    Front Cell Infect Microbiol; 2018; 8():210. PubMed ID: 30013953
    [No Abstract]   [Full Text] [Related]  

  • 16.
    Muangsombut V; Withatanung P; Srinon V; Chantratita N; Stevens MP; Blackwell JM; Korbsrisate S
    Front Cell Infect Microbiol; 2017; 7():350. PubMed ID: 28848712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic resistance in Burkholderia species.
    Rhodes KA; Schweizer HP
    Drug Resist Updat; 2016 Sep; 28():82-90. PubMed ID: 27620956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines].
    Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA
    Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Delivery of Ceftazidime for the Treatment of Melioidosis in a Murine Model.
    Ruiz SI; Bowen LE; Bailey MM; Berkland C
    Mol Pharm; 2018 Mar; 15(3):1371-1376. PubMed ID: 29363975
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Stockton JL; Khakhum N; Stevenson HL; Torres AG
    mSphere; 2023 Oct; 8(5):e0037823. PubMed ID: 37768049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.